#ESMO26: Navigating the beneficial use of #AI for #RealWorldEvidence generation while retaining GDPR compliance is a delicate balance. Rodrigo Dienstmann
discusses how federated learning platforms can help
#InsightsbyESMO ➡️ https://ow.ly/7On05100ZQr
#HealthcareInnovation
discusses how federated learning platforms can help
#InsightsbyESMO ➡️ https://ow.ly/7On05100ZQr
#HealthcareInnovation
October 27, 2026 at 7:00 PM
#ESMO26: Navigating the beneficial use of #AI for #RealWorldEvidence generation while retaining GDPR compliance is a delicate balance. Rodrigo Dienstmann
discusses how federated learning platforms can help
#InsightsbyESMO ➡️ https://ow.ly/7On05100ZQr
#HealthcareInnovation
discusses how federated learning platforms can help
#InsightsbyESMO ➡️ https://ow.ly/7On05100ZQr
#HealthcareInnovation
🌍 #ESMO26 has come to a close, but the connections continue! 🤝
From #LiquidBiopsy to #RealWorldEvidence, PMAC leaves Madrid inspired by new ideas, meaningful conversations and opportunities for collaboration.
Thank you to everyone who connected with us! 💙 #PrecisionOncology
From #LiquidBiopsy to #RealWorldEvidence, PMAC leaves Madrid inspired by new ideas, meaningful conversations and opportunities for collaboration.
Thank you to everyone who connected with us! 💙 #PrecisionOncology
October 29, 2026 at 3:15 PM
🌍 #ESMO26 has come to a close, but the connections continue! 🤝
From #LiquidBiopsy to #RealWorldEvidence, PMAC leaves Madrid inspired by new ideas, meaningful conversations and opportunities for collaboration.
Thank you to everyone who connected with us! 💙 #PrecisionOncology
From #LiquidBiopsy to #RealWorldEvidence, PMAC leaves Madrid inspired by new ideas, meaningful conversations and opportunities for collaboration.
Thank you to everyone who connected with us! 💙 #PrecisionOncology
ISPOR EU 2026 is just around the corner! Check out the full list of our presentations and book time with our team and make sure to stop by booth #611 during the meeting! lumanity.com/events/ispor...
#RealWorldEvidence #HEOR #ISPOREU2026
#RealWorldEvidence #HEOR #ISPOREU2026
October 29, 2026 at 12:04 PM
ISPOR EU 2026 is just around the corner! Check out the full list of our presentations and book time with our team and make sure to stop by booth #611 during the meeting! lumanity.com/events/ispor...
#RealWorldEvidence #HEOR #ISPOREU2026
#RealWorldEvidence #HEOR #ISPOREU2026
🤝 From connections to collaboration!
At #ESMO26, our PMAC members are coming together, exchanging ideas and building new partnerships.
🧬 United by a shared mission: advancing #PrecisionOncology through #LiquidBiopsy and #RealWorldEvidence.
Together, we make a difference!
At #ESMO26, our PMAC members are coming together, exchanging ideas and building new partnerships.
🧬 United by a shared mission: advancing #PrecisionOncology through #LiquidBiopsy and #RealWorldEvidence.
Together, we make a difference!
October 27, 2026 at 8:04 AM
🤝 From connections to collaboration!
At #ESMO26, our PMAC members are coming together, exchanging ideas and building new partnerships.
🧬 United by a shared mission: advancing #PrecisionOncology through #LiquidBiopsy and #RealWorldEvidence.
Together, we make a difference!
At #ESMO26, our PMAC members are coming together, exchanging ideas and building new partnerships.
🧬 United by a shared mission: advancing #PrecisionOncology through #LiquidBiopsy and #RealWorldEvidence.
Together, we make a difference!
#ESMO26 starts today! PMAC is in Madrid, connecting science, evidence & people. Join our members to discuss #LiquidBiopsy and #RealWorldEvidence in #PrecisionMedicine to explore collaborations. Let’s meet! 🤝
October 23, 2026 at 9:21 AM
#ESMO26 starts today! PMAC is in Madrid, connecting science, evidence & people. Join our members to discuss #LiquidBiopsy and #RealWorldEvidence in #PrecisionMedicine to explore collaborations. Let’s meet! 🤝
-3 days to #ESMO26! Are you ready? PMAC is heading to Madrid.
Our members are eager to exchange ideas on #LiquidBiopsy, #PrecisionOncology and #RealWorldEvidence.
Look out for our members during the meeting or send us a message to connect.
Attending? 🤝 Let’s talk!
Our members are eager to exchange ideas on #LiquidBiopsy, #PrecisionOncology and #RealWorldEvidence.
Look out for our members during the meeting or send us a message to connect.
Attending? 🤝 Let’s talk!
October 20, 2026 at 2:10 PM
-3 days to #ESMO26! Are you ready? PMAC is heading to Madrid.
Our members are eager to exchange ideas on #LiquidBiopsy, #PrecisionOncology and #RealWorldEvidence.
Look out for our members during the meeting or send us a message to connect.
Attending? 🤝 Let’s talk!
Our members are eager to exchange ideas on #LiquidBiopsy, #PrecisionOncology and #RealWorldEvidence.
Look out for our members during the meeting or send us a message to connect.
Attending? 🤝 Let’s talk!
#PhaseIV ≠ #RealWorldEvidence.
Phase IV: interventional trial, prospective protocol, mandated by regulators.
#RWE: observational, answers what trials can't.
Neither substitutes for the other.
#PostMarketing #Pharmacovigilance #ClinicalResearch #DrugDevelopment #CRO #ICHM14 #FDA #EMA
Phase IV: interventional trial, prospective protocol, mandated by regulators.
#RWE: observational, answers what trials can't.
Neither substitutes for the other.
#PostMarketing #Pharmacovigilance #ClinicalResearch #DrugDevelopment #CRO #ICHM14 #FDA #EMA
Phase IV vs Real-World Evidence: Two Different Tools That Solve Two Different Problems
Phase IV and real-world evidence are not interchangeable. Phase IV is an interventional trial mandated by FDA or EMA — RWE cannot substitute it.
genelifecr.blogspot.com
October 21, 2026 at 7:01 AM
#PhaseIV ≠ #RealWorldEvidence.
Phase IV: interventional trial, prospective protocol, mandated by regulators.
#RWE: observational, answers what trials can't.
Neither substitutes for the other.
#PostMarketing #Pharmacovigilance #ClinicalResearch #DrugDevelopment #CRO #ICHM14 #FDA #EMA
Phase IV: interventional trial, prospective protocol, mandated by regulators.
#RWE: observational, answers what trials can't.
Neither substitutes for the other.
#PostMarketing #Pharmacovigilance #ClinicalResearch #DrugDevelopment #CRO #ICHM14 #FDA #EMA
#News - This Week in Europe: @ispor.bsky.social #ISPOR Convenes Regulators, HTA Leaders, and Investors to Advance Integrated Evidence Generation. lnkd.in/p/gqxhFaN3
Convening Europe’s Evidence Leaders: ISPOR’s Path to Integrated Evidence Generation | ISPOR—The Professional Society for Health Economics and Outcomes Research
#News - This Week in Europe: ISPOR Convenes Regulators, HTA Leaders, and Investors to Advance Integrated Evidence Generation.
#HEOR #ISPOR #HTA #RealWorldEvidence #EUHTA #HealthPolicy
lnkd.in
October 19, 2026 at 1:38 PM
#News - This Week in Europe: @ispor.bsky.social #ISPOR Convenes Regulators, HTA Leaders, and Investors to Advance Integrated Evidence Generation. lnkd.in/p/gqxhFaN3
The countdown is on for the upcoming ISPOR EU 2026! For a full list of our presentations during the ISPOR EU meeting and our colleagues who will be in Vienna, visit: lumanity.com/events/ispor...
#RealWorldEvidence #Pharmacoepidemiology #HEOR
#RealWorldEvidence #Pharmacoepidemiology #HEOR
October 15, 2026 at 11:02 AM
The countdown is on for the upcoming ISPOR EU 2026! For a full list of our presentations during the ISPOR EU meeting and our colleagues who will be in Vienna, visit: lumanity.com/events/ispor...
#RealWorldEvidence #Pharmacoepidemiology #HEOR
#RealWorldEvidence #Pharmacoepidemiology #HEOR
Regulatory approval is the midpoint of the evidence journey — not the end.
#PhaseIV, #Pharmacovigilance, #RealWorldEvidence. All mandatory. All being held to higher standards.
In March 2026, ICH M14 raised the bar for post-marketing observational research significantly.
#ClinicalResearch #CRO
#PhaseIV, #Pharmacovigilance, #RealWorldEvidence. All mandatory. All being held to higher standards.
In March 2026, ICH M14 raised the bar for post-marketing observational research significantly.
#ClinicalResearch #CRO
Phase IV Clinical Trials and Post-Marketing Surveillance: Why Approval Is the Beginning of the Evidence Journey, Not Its End
Phase IV Clinical Trials and Post-Marketing Surveillance: ICH M14, PASS, PAES and RWE | Genelife CRO
genelifecr.blogspot.com
October 13, 2026 at 6:03 PM
Regulatory approval is the midpoint of the evidence journey — not the end.
#PhaseIV, #Pharmacovigilance, #RealWorldEvidence. All mandatory. All being held to higher standards.
In March 2026, ICH M14 raised the bar for post-marketing observational research significantly.
#ClinicalResearch #CRO
#PhaseIV, #Pharmacovigilance, #RealWorldEvidence. All mandatory. All being held to higher standards.
In March 2026, ICH M14 raised the bar for post-marketing observational research significantly.
#ClinicalResearch #CRO
Regulatory approval is the midpoint of the evidence journey — not the end.
#PhaseIV, #Pharmacovigilance, #RealWorldEvidence. All mandatory. All being held to higher standards.
In March 2026, ICH M14 raised the bar for post-marketing observational research significantly.
#ClinicalResearch #CRO
#PhaseIV, #Pharmacovigilance, #RealWorldEvidence. All mandatory. All being held to higher standards.
In March 2026, ICH M14 raised the bar for post-marketing observational research significantly.
#ClinicalResearch #CRO
Phase IV Clinical Trials and Post-Marketing Surveillance: Why Approval Is the Beginning of the Evidence Journey, Not Its End
Phase IV Clinical Trials and Post-Marketing Surveillance: ICH M14, PASS, PAES and RWE | Genelife CRO
genelifecr.blogspot.com
October 11, 2026 at 6:05 PM
Regulatory approval is the midpoint of the evidence journey — not the end.
#PhaseIV, #Pharmacovigilance, #RealWorldEvidence. All mandatory. All being held to higher standards.
In March 2026, ICH M14 raised the bar for post-marketing observational research significantly.
#ClinicalResearch #CRO
#PhaseIV, #Pharmacovigilance, #RealWorldEvidence. All mandatory. All being held to higher standards.
In March 2026, ICH M14 raised the bar for post-marketing observational research significantly.
#ClinicalResearch #CRO
💡 Switch is about more than reclassification.
At #SwitchDay2026, speakers highlighted how #RealWorldEvidence, community pharmacists, digital tools and regulatory dialogue can improve #PatientAccess while maintaining high standards of safety and efficacy.
At #SwitchDay2026, speakers highlighted how #RealWorldEvidence, community pharmacists, digital tools and regulatory dialogue can improve #PatientAccess while maintaining high standards of safety and efficacy.
October 7, 2026 at 11:49 AM
💡 Switch is about more than reclassification.
At #SwitchDay2026, speakers highlighted how #RealWorldEvidence, community pharmacists, digital tools and regulatory dialogue can improve #PatientAccess while maintaining high standards of safety and efficacy.
At #SwitchDay2026, speakers highlighted how #RealWorldEvidence, community pharmacists, digital tools and regulatory dialogue can improve #PatientAccess while maintaining high standards of safety and efficacy.
Thank you to all national coordinators, data managers and centres who make this possible! 🤝
Being a network is what makes RADeep work!
#RareAnaemias #SickleCellDisease #RealWorldEvidence #EHDS
@erneurobloodnet.bsky.social
Being a network is what makes RADeep work!
#RareAnaemias #SickleCellDisease #RealWorldEvidence #EHDS
@erneurobloodnet.bsky.social
October 7, 2026 at 1:34 PM
Thank you to all national coordinators, data managers and centres who make this possible! 🤝
Being a network is what makes RADeep work!
#RareAnaemias #SickleCellDisease #RealWorldEvidence #EHDS
@erneurobloodnet.bsky.social
Being a network is what makes RADeep work!
#RareAnaemias #SickleCellDisease #RealWorldEvidence #EHDS
@erneurobloodnet.bsky.social
📊 Dane, które pracują – jak wykorzystać dane z codziennej praktyki klinicznej do wzmocnienia potencjału badawczego szpitali?
O tym podczas #22 edycji MEDmeetsTECH opowie Wojciech Makara
#MEDmeetsTECH #MedTech #Healthcare #RWE #RealWorldEvidence #EHDS #DaneMedyczne
O tym podczas #22 edycji MEDmeetsTECH opowie Wojciech Makara
#MEDmeetsTECH #MedTech #Healthcare #RWE #RealWorldEvidence #EHDS #DaneMedyczne
September 28, 2026 at 8:17 AM
📊 Dane, które pracują – jak wykorzystać dane z codziennej praktyki klinicznej do wzmocnienia potencjału badawczego szpitali?
O tym podczas #22 edycji MEDmeetsTECH opowie Wojciech Makara
#MEDmeetsTECH #MedTech #Healthcare #RWE #RealWorldEvidence #EHDS #DaneMedyczne
O tym podczas #22 edycji MEDmeetsTECH opowie Wojciech Makara
#MEDmeetsTECH #MedTech #Healthcare #RWE #RealWorldEvidence #EHDS #DaneMedyczne
Cross-border data access could unlock more robust real-world evidence across Europe. Discover what EHDS means for sponsors and CROs. https://ow.ly/Kl7A50ZxmiG
#EHDS #RealWorldEvidence #ClinicalResearch
#EHDS #RealWorldEvidence #ClinicalResearch
September 15, 2026 at 9:00 AM
Cross-border data access could unlock more robust real-world evidence across Europe. Discover what EHDS means for sponsors and CROs. https://ow.ly/Kl7A50ZxmiG
#EHDS #RealWorldEvidence #ClinicalResearch
#EHDS #RealWorldEvidence #ClinicalResearch
📢 Call for Papers: AI for Real-World Evidence Generation in Biomedicine
⏳ Submission Deadline: 31 January 2027
🔗 Submit your work: spj.science.org/journal/csbj...
@csbj.org #RealWorldEvidence #RWE #BiomedicalAI #ClinicalInformatics #BiomarkerDiscovery #PrecisionMedicine #DigitalHealth
⏳ Submission Deadline: 31 January 2027
🔗 Submit your work: spj.science.org/journal/csbj...
@csbj.org #RealWorldEvidence #RWE #BiomedicalAI #ClinicalInformatics #BiomarkerDiscovery #PrecisionMedicine #DigitalHealth
September 4, 2026 at 4:26 AM
📢 Call for Papers: AI for Real-World Evidence Generation in Biomedicine
⏳ Submission Deadline: 31 January 2027
🔗 Submit your work: spj.science.org/journal/csbj...
@csbj.org #RealWorldEvidence #RWE #BiomedicalAI #ClinicalInformatics #BiomarkerDiscovery #PrecisionMedicine #DigitalHealth
⏳ Submission Deadline: 31 January 2027
🔗 Submit your work: spj.science.org/journal/csbj...
@csbj.org #RealWorldEvidence #RWE #BiomedicalAI #ClinicalInformatics #BiomarkerDiscovery #PrecisionMedicine #DigitalHealth
📍 Reporting live from #ISPEAnnual2026 in Milan!
The Teamit team is on site at the International Society for Pharmacoepidemiology Annual Meeting for the 5th consecutive year.
If you're attending ISPE 2026, come and say hello!
#ISPEAnnual2026 #Pharmacoepidemiology #RealWorldEvidence #DrugSafety
The Teamit team is on site at the International Society for Pharmacoepidemiology Annual Meeting for the 5th consecutive year.
If you're attending ISPE 2026, come and say hello!
#ISPEAnnual2026 #Pharmacoepidemiology #RealWorldEvidence #DrugSafety
September 2, 2026 at 8:35 AM
📍 Reporting live from #ISPEAnnual2026 in Milan!
The Teamit team is on site at the International Society for Pharmacoepidemiology Annual Meeting for the 5th consecutive year.
If you're attending ISPE 2026, come and say hello!
#ISPEAnnual2026 #Pharmacoepidemiology #RealWorldEvidence #DrugSafety
The Teamit team is on site at the International Society for Pharmacoepidemiology Annual Meeting for the 5th consecutive year.
If you're attending ISPE 2026, come and say hello!
#ISPEAnnual2026 #Pharmacoepidemiology #RealWorldEvidence #DrugSafety
Mike Klein, CEO of #Genomenon, tells us how his company's human and #AI curators mine the global scientific literature for evidence describing genetic variants
🎧 Listen now → ontargetpodcast.com
#OnTarget #PrecisionMedicine #Genomics #RealWorldEvidence #RareDisease #Diagnostics #DataInfrastructure
🎧 Listen now → ontargetpodcast.com
#OnTarget #PrecisionMedicine #Genomics #RealWorldEvidence #RareDisease #Diagnostics #DataInfrastructure
August 20, 2026 at 12:58 AM
Mike Klein, CEO of #Genomenon, tells us how his company's human and #AI curators mine the global scientific literature for evidence describing genetic variants
🎧 Listen now → ontargetpodcast.com
#OnTarget #PrecisionMedicine #Genomics #RealWorldEvidence #RareDisease #Diagnostics #DataInfrastructure
🎧 Listen now → ontargetpodcast.com
#OnTarget #PrecisionMedicine #Genomics #RealWorldEvidence #RareDisease #Diagnostics #DataInfrastructure
Strong #realworldevidence #RWE data from #Australia: maternal #RSV #vaccination was 80.8% effective against RSV-related hospitalization through 6 months of age. #VaccinesWork #VaccinesSaveLives www.linkedin.com/posts/drmelv...
August 18, 2026 at 8:59 PM
Strong #realworldevidence #RWE data from #Australia: maternal #RSV #vaccination was 80.8% effective against RSV-related hospitalization through 6 months of age. #VaccinesWork #VaccinesSaveLives www.linkedin.com/posts/drmelv...
How will the European Health Data Space reshape real-world evidence generation? ICON explores the opportunities, challenges and implications for CROs. https://ow.ly/Hwwc50Zxm9s
#EHDS #RealWorldEvidence #ClinicalResearch
#EHDS #RealWorldEvidence #ClinicalResearch
August 12, 2026 at 3:00 PM
How will the European Health Data Space reshape real-world evidence generation? ICON explores the opportunities, challenges and implications for CROs. https://ow.ly/Hwwc50Zxm9s
#EHDS #RealWorldEvidence #ClinicalResearch
#EHDS #RealWorldEvidence #ClinicalResearch
The world of clinical trials is evolving from rigid to "Pragmatic & Adaptive." ECT proves that past data can save future lives.
Have you ever worked with External Controls or Synthetic Arms? Let’s discuss below! 👇
#PeerOnSky #ClinicalTrials #ExternalControlledTrials #RealWorldEvidence
Have you ever worked with External Controls or Synthetic Arms? Let’s discuss below! 👇
#PeerOnSky #ClinicalTrials #ExternalControlledTrials #RealWorldEvidence
February 13, 2026 at 9:17 AM
The world of clinical trials is evolving from rigid to "Pragmatic & Adaptive." ECT proves that past data can save future lives.
Have you ever worked with External Controls or Synthetic Arms? Let’s discuss below! 👇
#PeerOnSky #ClinicalTrials #ExternalControlledTrials #RealWorldEvidence
Have you ever worked with External Controls or Synthetic Arms? Let’s discuss below! 👇
#PeerOnSky #ClinicalTrials #ExternalControlledTrials #RealWorldEvidence
📣Thrilled to share our pan-European collaboration results: mepolizumab delivers progressive,real-world benefits in #CRSwNP! Nearly 50% achieved a deep composite response at 1 year, proving the power of staying the course.A huge team effort!
#biologics #RealWorldEvidence
🔗 dx.doi.org/10.1002/clt2...
#biologics #RealWorldEvidence
🔗 dx.doi.org/10.1002/clt2...
Real‐World Effectiveness of Mepolizumab in Patients With Chronic Rhinosinusitis With Nasal Polyps: Findings From the European CRS Outcome Registry (CHRINOSOR)
Background The SYNAPSE phase 3 study demonstrated that mepolizumab significantly improves nasal polyp score (NPS), quality of life and symptom severity in patients with chronic rhinosinusitis with n...
dx.doi.org
February 3, 2026 at 5:19 AM
📣Thrilled to share our pan-European collaboration results: mepolizumab delivers progressive,real-world benefits in #CRSwNP! Nearly 50% achieved a deep composite response at 1 year, proving the power of staying the course.A huge team effort!
#biologics #RealWorldEvidence
🔗 dx.doi.org/10.1002/clt2...
#biologics #RealWorldEvidence
🔗 dx.doi.org/10.1002/clt2...
📢 Read this week’s #OpenPharma digest here!
Sign up to our blog to receive weekly #OpenScience news and more straight to your inbox!
#OpenAccess #AItoolkit #eLife #realworlddata #realworldevidence #PPIE #OApublishing #OASPA #DefendResearch #OpenResearch
Sign up to our blog to receive weekly #OpenScience news and more straight to your inbox!
#OpenAccess #AItoolkit #eLife #realworlddata #realworldevidence #PPIE #OApublishing #OASPA #DefendResearch #OpenResearch
Weekly digest: AI-powered toolkit for publishing, real-world data and #DefendResearch
This week, we learn how a collaborative group co-created tools for meaningful PPIE in RWDE research and examine the role of an AI-powered toolkit in a publisher’s workflow. We consider an argument aga...
www.openpharma.blog
February 28, 2025 at 1:09 PM
📢 Read this week’s #OpenPharma digest here!
Sign up to our blog to receive weekly #OpenScience news and more straight to your inbox!
#OpenAccess #AItoolkit #eLife #realworlddata #realworldevidence #PPIE #OApublishing #OASPA #DefendResearch #OpenResearch
Sign up to our blog to receive weekly #OpenScience news and more straight to your inbox!
#OpenAccess #AItoolkit #eLife #realworlddata #realworldevidence #PPIE #OApublishing #OASPA #DefendResearch #OpenResearch